Can an FDA-approved drug help halt vision loss in MS?
At its annual honors and awards ceremony on Thursday, OMRF presented Christy Everest with its Board of Directors Distinguished Service Award.
OMRF scientist Scott Plafker has received a four-year grant from the NIH to study whether a natural compound can help prevent a common eye disease.
For nearly 20 percent of MS patients, vision loss is the first symptom.
Awards “a testament to the quality of research in Oklahoma”
Scott and Kendra Plafker are still achieving firsts after 17 years of marriage.